The chemical class of RNF148 Inhibitors comprises a specialized group of compounds designed to target and modulate the activity of RNF148, a ring finger protein involved in the ubiquitin-proteasome system within cells. The development of inhibitors for RNF148 represents a complex and nuanced approach to influence the functions of this protein, particularly its role in tagging proteins for ubiquitination and subsequent degradation. By focusing on the inhibition of RNF148, these compounds aim to alter its interaction with E2 ubiquitin-conjugating enzymes and substrate proteins, impacting the protein's role in maintaining protein homeostasis within the cell.
The mechanism of action of RNF148 inhibitors is centered around disrupting the E3 ligase activity of RNF148, which is crucial for the ubiquitination of substrate proteins. By inhibiting this activity, these compounds seek to diminish the efficiency of RNF148 in the ubiquitination process, thereby affecting the overall protein turnover within the cell. This approach is vital for understanding the mechanisms underlying protein ubiquitination and degradation, as well as the protein's role in various cellular processes such as signal transduction, cell cycle progression, and apoptosis. Furthermore, these inhibitors are designed to influence the interaction of RNF148 with other components of the ubiquitination machinery. This aspect is crucial for understanding the protein's role in the larger context of cellular protein regulation and the complex interplay of various metabolic pathways. The exploration of RNF148 inhibitors highlights the importance of targeted molecular interventions in the study of protein regulation and cellular homeostasis. By modulating the activity of RNF148, these inhibitors offer insights into the protein's role within the ubiquitin-proteasome system and provide a means to explore the consequences of altering this system at a molecular level. The study of RNF148 inhibitors is not just about understanding a single protein's function; it represents a broader endeavor to comprehend the dynamic interplay of protein regulation in cellular health. RNF148 inhibitors serve as a tool to dissect the intricate roles of the ubiquitin-proteasome system in cellular functions, providing insights into the delicate equilibrium of protein metabolism. Through their specific action on RNF148, these inhibitors contribute significantly to the field of molecular biology, emphasizing the potential of focused molecular strategies in unraveling complex biological processes. They underscore the intricate connections between protein regulation, cellular health, and the delicate regulatory mechanisms that maintain cellular equilibrium. Through their targeted action, RNF148 inhibitors serve as critical tools in unraveling the nuances of protein ubiquitination and cellular function, providing insights into the complex balance of protein homeostasis within cells.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Could possibly inhibit RNF148 by inhibiting the proteasome, impacting protein degradation. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Might inhibit RNF148 by blocking the proteasome, affecting protein degradation pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Could inhibit RNF148 by proteasome inhibition, affecting ubiquitination processes. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $104.00 | 8 | |
Might inhibit RNF148 by disrupting NEDD8-activating enzyme, affecting ubiquitin ligase activity. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Could inhibit RNF148 by inhibiting the ubiquitin-activating enzyme, impacting ubiquitination. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Could inhibit RNF148 by proteasome inhibition, affecting downstream protein degradation. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Could inhibit RNF148 by inhibiting the proteasome, impacting protein degradation processes. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Might inhibit RNF148 as a proteasome inhibitor, impacting the ubiquitination pathway. |